UNIVERSITY OF ARIZONA
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 1885-01-01
- Employees
- 10K
- Market Cap
- -
- Website
- http://www.arizona.edu
Pharmacogenomics of Heparin-Induced Thrombocytopenia
Recruiting
- Conditions
- Heparin-induced Thrombocytopenia
- Interventions
- Procedure: Blood Draw
- First Posted Date
- 2016-03-23
- Last Posted Date
- 2024-06-27
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 125
- Registration Number
- NCT02717039
- Locations
- 🇺🇸
Banner University Medical Center - Tucson, Tucson, Arizona, United States
Inspiratory Muscle Strength Training for Sleep-related Breathing Disorders
Not Applicable
Completed
- Conditions
- Obstructive Sleep Apnea
- Interventions
- Other: Inspiratory muscle strength trainingOther: Placebo
- First Posted Date
- 2016-03-16
- Last Posted Date
- 2017-11-29
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 25
- Registration Number
- NCT02709941
- Locations
- 🇺🇸
Department of Physiology at the University of Arizona, Tucson, Arizona, United States
Promoting Adherence to Treatment for Latent TB Infection Through Text Messaging
Not Applicable
Completed
- Conditions
- Latent Tuberculosis
- Interventions
- Behavioral: Regularly scheduled LTBI medication reminder text messages
- First Posted Date
- 2016-02-24
- Last Posted Date
- 2019-04-23
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 30
- Registration Number
- NCT02690818
- Locations
- 🇺🇸
Pima County Health Department, Tucson, Arizona, United States
Investigating Transcranial Ultrasound as a Potential Intervention for Depression
Not Applicable
Completed
- Conditions
- DepressionAnxiety Disorders
- Interventions
- Device: Transcranial Ultrasound PowerDevice: Transcranial Ultrasound Sham
- First Posted Date
- 2016-02-18
- Last Posted Date
- 2018-01-08
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 26
- Registration Number
- NCT02685488
Photodynamic Therapy and Vismodegib for Multiple Basal Cell Carcinomas
- First Posted Date
- 2015-12-24
- Last Posted Date
- 2018-07-18
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 4
- Registration Number
- NCT02639117
- Locations
- 🇺🇸
Arizona Cancer Center, Tucson, Arizona, United States
Brentuximab Vedotin, Bendamustine, and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma
Phase 2
Withdrawn
- Conditions
- High Grade B Cell LymphomaMarginal Zone LymphomaSmall Lymphocytic LymphomaDiffuse Large B Cell LymphomaMediastinal Large B-cell LymphomaGrey Zone LymphomaFollicular Lymphoma
- Interventions
- First Posted Date
- 2015-12-08
- Last Posted Date
- 2017-05-19
- Lead Sponsor
- University of Arizona
- Registration Number
- NCT02623920
- Locations
- 🇺🇸
Arizona Cancer Center at UMC North, Tucson, Arizona, United States
Wearable Sensor-based Balance Training for Patients With Knee Osteoarthritis
Not Applicable
- Conditions
- Knee Osteoarthritis
- Interventions
- Device: Wearable sensor-based exercise training
- First Posted Date
- 2015-12-03
- Last Posted Date
- 2016-05-17
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 24
- Registration Number
- NCT02620462
- Locations
- 🇺🇸
The University of Arizona Arthritis Center, Tucson, Arizona, United States
Electro-acupuncture for Gait and Balance in Parkinson's Disease
Not Applicable
Completed
- Conditions
- Parkinson's Disease
- Interventions
- Procedure: ElectroacupunctureOther: Body-worn sensor technology
- First Posted Date
- 2015-09-22
- Last Posted Date
- 2017-11-09
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 15
- Registration Number
- NCT02556164
Evaluation of the Metformin Effect on Methylglyoxal in Patients With Type 2 Diabetes
Not Applicable
- Conditions
- Type 2 Diabetes Mellitus
- Interventions
- Other: Glucometer (One Touch glucometer), strips and lancetsOther: Urine container for 24-hour urine collection
- First Posted Date
- 2015-09-14
- Last Posted Date
- 2015-09-14
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 120
- Registration Number
- NCT02548741
Curcuma Longa L in Rheumatoid Arthritis
Phase 1
Terminated
- Conditions
- Rheumatoid Arthritis
- Interventions
- Drug: MerivaDrug: placebo
- First Posted Date
- 2015-09-07
- Last Posted Date
- 2016-11-30
- Lead Sponsor
- University of Arizona
- Target Recruit Count
- 3
- Registration Number
- NCT02543931
- Locations
- 🇺🇸
The University of Arizona, Tucson, Arizona, United States
© Copyright 2025. All Rights Reserved by MedPath